General Information of Drug Therapeutic Target (DTT) (ID: TTMBO1Z)

DTT Name Cyclin-dependent kinase (CDK)
Synonyms Cyclin dependent kinase
Gene Name CDK
DTT Type
Clinical trial target
[1]
UniProt ID
NOUNIPROTAC
TTD ID
T70508

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
4 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Flavopiridol DMKSUOI Acute myeloid leukaemia 2A60 Phase 2 [2]
R-roscovitine DMSH108 Non-small-cell lung cancer 2C25.Y Phase 2 [1]
TG02 DMZFIGQ Anaplastic astrocytoma 2A00.0 Phase 1/2 [3]
PF-06873600 DMRZHV6 Breast cancer 2C60-2C65 Phase 1 [3]
------------------------------------------------------------------------------------
4 Patented Agent(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indole-based analog 12 DM1CNRH N. A. N. A. Patented [4]
PMID26161698-Compound-10 DMXVCHZ N. A. N. A. Patented [4]
PMID26161698-Compound-44 DM8UPO3 N. A. N. A. Patented [4]
Purine derivative 4 DMYD5SQ N. A. N. A. Patented [4]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
BS-194 DMLXFHD Solid tumour/cancer 2A00-2F9Z Investigative [5]
------------------------------------------------------------------------------------

References

1 Therapeutic efficacy of seliciclib in combination with ionizing radiation for human nasopharyngeal carcinoma.Clin Cancer Res. 2009 Jun 1;15(11):3716-24.
2 Pharma & Vaccines. Product Development Pipeline. April 29 2009.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).Expert Opin Ther Pat. 2015;25(9):953-70.
5 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8176).